By suppressing T cell anti-tumor activity through the release of immune-suppressing proteins like IL-10 and IL-4, the M2-like TME promotes tumor growth by relying on oxidative phosphorylation (OXPHOS) and fatty acid oxidation (FAO). Here, IL4 is linked to neoplasm.